The over-prescribing of opioids following urological surgery places patients at risk for opioid overuse and dependency. However, no guidelines exist to help urologists consistently prescribe appropriate quantities of pain medication. We sought to characterize the variation in opioid prescribing habits at time of discharge following nephrectomy.
factors, and impact of CDI on perioperative outcomes in urologic surgery.
METHODS: The American College of Surgeons National Surgical Quality Improvement Project (ACS NSQIP) database tracts 30-day hospital readmission, reoperation, death, and complications, including CDI, from participating institutions. We identified CPT codes of patients undergoing the breadth of urologic surgery, which we characterized into 12 surgical categories (Figure 1 ). Univariate analysis was used to compare preoperative and operative parameters associated with the outcomes of interest (CDI, readmission, and death). Variables that were significant or near significant were entered into a multivariable backwards stepwise logistic regression model. All tests were 2 sided and significance was set at p[0.05.
RESULTS: From 2015-2016, we identified 83,646 patients with urology associated CPT codes, of which 281 patients (0.3%) developed postoperative CDI. CDI was highest in patients undergoing urinary diversion with (2.6%) or without cystectomy (3.6%), Figure 1 . In the multivariable model, male gender was protective against CDI (OR 0.657, p[0.017) CONCLUSIONS: Although, CDI is relatively uncommon in most urologic surgery, there is significant morbidity and mortality associated with CDI. Awareness of predisposing risk factors may provide insight to decrease the incidence and impact of CDI. Genitourinary reconstructive surgery often involves patient populations at risk for reduced tissue perfusion. In the setting of complex fistula disease, many patients have significant history of external beam radiation therapy, further compromising blood flow. Previous method of intraoperative assessment of tissue viability relied on direct surgeon visualization. SPY-PHI (Stryker Kalamazoo, Michigan), is a portable hand held device using near-infrared laser technology and indocyanine green to assess for tissue perfusion. We sought to compare subjective intraoperative surgeon assessment of tissue perfusion to objective perfusion using SPY-PHI technology.
METHODS: We utilized SPY-PHI in a cohort of 8 patients undergoing open, complex genitourinary reconstructive surgery for acute trauma or complex fistula disease between September 2017 and November 2018 at Mayo Clinic.
RESULTS: Seven patients in our cohort underwent multimodality reconstructive surgery due to fistulous disease as a result of prior radiation therapy. In 7 of 8 cases, discordant subjective intraoperative surgeon assessment of tissue viability was seen when compared to assessment of tissue perfusion using SPY-PHI. The most common difference noted was in evaluation of the length of ureteral viability.
CONCLUSIONS: In our recent experience, near-infrared laser assessment using SPY-PHI technology is a useful adjunct for realtime intraoperative evaluation of tissue viability in complex genitourinary reconstructive surgery. More short and long-term data are necessary to evaluate the potential role of SPY-PHI technology in genitourinary reconstructive surgery.
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V09-02 ROBOT ASSISTED SALVAGE RETROPERITONEAL LYMPH NODE DISSECTION OF RETROCRURAL TERATOMA
Anojan Navaratnam*, William Critchlow, Haidar Abdul-Muhsin, Erik Castle, Phoenix, AZ INTRODUCTION AND OBJECTIVES: Robot assisted retroperitoneal lymph node dissection (RARPLND) for testicular cancer is emerging as a minimally invasive approach to residual retroperitoneal mass following chemotherapy. This operation is associated with high operative risk due to the intimate involvement of these masses to the great vessels. In particular, dissection superior to the renal vessels can be associated with a higher risk of injury to the thoracic duct and arterial supply to the intestines. Although template dissection robotically has been demonstrated to be feasible and safe, resection of masses outside of a standard template can be difficult due to accessibility and exposure. This unique video demonstrates dissection of retrocrural masses superior to the standard template RARPLND.
METHODS: A 37 year old male with a history of metastatic testicular cancer underwent salvage RARPLD for residual retrocrural masses. This complex patient had previously undergone open RPLND at an outside center followed by chemotherapy after initial diagnosis. Subsequently he underwent thoracotomy with mediastinal lymph node dissection with T4/5 laminectomy and vertebral fixation and finally a sternotomy for further mediastinal lymph node dissection. The retrocrural masses were his only remaining disease.
This was done with a transabdominal approach and the patient positioned in a left side up modified flank position. This video demonstrates retrocrural dissection posterior to the aorta with division of the crus of the diaphragm.
RESULTS: The operation was conducted successfully with no immediate surgical complications. Key structures include the superior mesenteric and celiac arteries were identified and preserved. The left crus of the diaphragm was split in order to expose the retrocrual mass. The second retrocrural mass behind the right crus of the diaphragm was able to be dissected from behind the aorta without repositioning the patient.
Total operative time was 4 hours with an estimated blood loss of 25mL. There was no need to reposition the patient and they were
